Previous Close | 3.0700 |
Open | 3.0800 |
Bid | 3.1500 x 800 |
Ask | 3.1900 x 900 |
Day's Range | 3.0800 - 3.1900 |
52 Week Range | 2.1200 - 19.9500 |
Volume | |
Avg. Volume | 507,980 |
Market Cap | 120.661M |
Beta (5Y Monthly) | 2.20 |
PE Ratio (TTM) | N/A |
EPS (TTM) | -1.8800 |
Earnings Date | May 15, 2023 - May 19, 2023 |
Forward Dividend & Yield | N/A (N/A) |
Ex-Dividend Date | N/A |
1y Target Est | 22.63 |
Subscribe to Yahoo Finance Plus to view Fair Value for MNMD
NEW YORK, March 09, 2023--Mind Medicine (MindMed) Inc. today reported its financial results for the full-year ended December 31, 2022.
NEW YORK, February 28, 2023--Mind Medicine (MindMed) Inc. (NASDAQ: MNMD), (NEO: MMED), (the "Company" or "MindMed"), a clinical stage biopharmaceutical company developing novel product candidates to treat brain health disorders, today announced that members of the Company's management team will participate in the following investor conferences:
By Exec Edge Editorial Staff Lucy Scientific Discovery Inc. (Nasdaq: LSDI), which focuses on psychotropic drugs and had its initial public offering last week, rang the closing bell at the Nasdaq stock exchange today in New York. The company is focused on becoming the premier research, development, and manufacturing organization for the emerging psychedelics-based medicines […]